To,
The Members
EMA Partners India Limited
(formerly known as EMA Partners India Private Limited)
Your directors have the pleasure of presenting the 22nd Annual Report of EMA Partners India Limited ("Your Company/ The Company") together with the Audited Standalone & Consolidated Financial Statements and the Auditors report for the Financial Year ended 31st March, 2025 ("year under review").
The consolidated performance of the Company and its subsidiaries is referred to wherever necessary.
1. COMPANY OVERVIEW:
The Company was incorporated in 2003 and is a member firm of EMA Partners International Ltd, a global network of executive search firms present in over 30 countries. The Company is a leading executive search and leadership advisory firm headquartered in Mumbai. The Company has expanded its footprint with subsidiaries in Singapore (2010) and Dubai (2017), enhancing access to international talent pools.
In January 2025, EMA Partners India became the first executive search firm to list on the Indian Stock Exchange (NSE-Emerge), marking a significant milestone for the Company and our industry.
2. FINANCIAL SUMMARY AND HIGHLIGHTS OF PERFORMANCE:
Key highlights of the financial performance of your Company for the financial year 2024-25 are provided below:-
Particulars | Standalone | Consolidated | ||
FY 2024-25 | FY 2023-24 | FY 2024-25 | FY 2023-24 | |
Revenue from Operations | 1,09,353.17 | 1,43,563.77 | 7,39,304.98 | 6,72,962.46 |
Other Income | 45,070.87 | 17,879.31 | 50,824.62 | 15,382.65 |
Total Income | 1,54,424.04 | 1,61,443.08 | 7,90,129.60 | 6,88,345.11 |
Total Expenses | 1,12,936.95 | 1,30,481.00 | 6,06,094.20 | 5,08,105.13 |
Profit before Depreciation and finance cost | 41,487.09 | 30,962.08 | 1,84,035.4 | 1,80,239.98 |
Depreciation and Amortisation expenses | 12,499.91 | 7,340.00 | 20,461.53 | 1 1,570.33 |
Finance Cost | 4,730.75 | 1,137.56 | 5,491.58 | 1,862.12 |
Profit before exceptional items and tax | 24,256.43 | 22,484.52 | 1,58,082.29 | 1,66,807.53 |
Exceptional items | -- | -- | -- | -- |
Profit before tax | 24,256.43 | 22,484.52 | 1,58,082.29 | 1,66,807.53 |
Tax expense | 4,527.73 | 5,973.72 | 33,693.47 | 20,635.91 |
Minority Interest | -- | -- | (1,749.68) | 3,443.24 |
Profit / (Loss) for the year | 19,728.70 | 16,510.80 | 1,26,138.50 | 1,42,728.38 |
Basic EPS (in f) | 1.06 | 0.97 | 6.81 | 8.40 |
Diluted EPS (in f) | 1.05 | 0.97 | 6.73 | 8.40 |
3. TRANSFER TO RESERVES:
The Board of Directors has not appropriated and transferred any amount to any Reserve and the Board has decided to retain the entire amount in the Profit and Loss account.
4. CHANGE IN THE NATURE OF BUSINESS OF THE COMPANY:
The Company did not undergo any change in the nature of its business during the year under review.
5. BUSINESS AND REVIEW OF OPERATIONS / STATE OF AFFAIRS OF THE COMPANY / KEY HIGHLIGHTS:
Your Company is one of the leading executive search firms delivering customized leadership hiring solutions for a wide range of clients across diverse sectors. Your Company has recruited several business and functional leaders for domestic and international clients.
Your Company, headquartered in Mumbai, has offices in Chennai, Gurgaon, and Bengaluru.
To tap into the global talent and client pool, we expanded our operations in Southeast Asia by setting up a subsidiary EMA Partners Singapore Pte Ltd in Singapore in September 2010. Later, we identified growth opportunities in the Middle East and established two subsidiaries: EMA Partners Executive Search Limited (Dubai) in March 2017 and James Douglas Professional Search Limited (Dubai) in July 2022.
Your Directors wish to present the details of the Business Operations done during the year under review:
The Companys Revenue from Operations for the year under review, on a consolidated basis, increased to Rs. 7,39,304.98/- (in Thousand) from Rs. 6,72,962.46/- (in Thousand) during the previous year. The Company achieved an EBITDA (excluding other income and exceptional items) of Rs. 1,33,210.79/- (in Thousand) during the current year as against the previous years EBITDA (excluding other income and exceptional items) of Rs. 1,64,857.34/- (in Thousand). Net profit after tax stood at Rs. 1,26,138.50/- (in Thousand), maintaining a strong bottom-line performance.
6. MATERIAL CHANGES AND
COMMITMENTS AFFECTING
FINANCIAL POSITION BETWEEN THE END OF THE FINANCIAL YEAR AND DATE OF THE REPORT:
No material changes and commitments occurred after the closure of the Financial Year 2024-25 till the date of this Report, which would materially impact the financial position of your Company.
7. OUTLOOK:
Details on the Companys strategic direction, opportunities and growth initiatives are discussed in the Management Discussion and Analysis Report, which forms an integral part of this Annual Report.
8. SHARE CAPITAL:
a) Increase in Authorized Share Capital
During the year under review, the Authorized Share Capital of the Company increased to Rs.15,00,00,000/- (Rupees Fifteen Crores Only) divided into 15,00,00,000 Equity Shares of Rs. 1/- each, effective from July 10, 2024.
b) Consolidation of the share capital
The face value of Authorised, Issued, Subscribed and Paid-up Share Capital of the Company was consolidated from Rs. 1/- each to
Rs. 5/- each effective from July 10, 2024. Thereby, the Authorised Share Capital of the Company consisting of 15,00,00,000 Equity Shares of face value of Rs. 1/- each is consolidated to 3,00,00,000 Equity Shares of face value of Rs. 5/- each.
The issued, subscribed and paid-up capital of 4,22,850 Equity Shares of face value of Rs. 1/- each consolidated into 84,570 Equity Shares of face value of Rs. 5/- each.
c) Bonus Shares
With a view of proposed business plans of the Company and to satisfy the expectations of the shareholders, the Company issued and allotted
1.69.14.000 Bonus Equity Shares to its existing shareholders in the ratio of 200:1 i.e. 200 (Two Hundred) Bonus Equity Shares of face value of Rs. 5/- each for every existing 1 (One) Equity Share of face value of Rs. 5/- each on August 17, 2024.
Post such allotment, the issued, subscribed and paid-up share capital of the Company increased to Rs. 8,49,92,850/- (Rupees Eight Crore Forty-Nine Lakhs Ninety-Two Thousand Eight Hundred and Fifty only).
d) Preferential Issue
The Company issued and allotted 9,13,856 Equity Shares of Rs. 5/- each at a premium of Rs. 99/- each aggregating to Rs. 9,50,41,024 /- (Rupees Nine Crore Fifty Lakhs Forty-One Thousand and Twenty Four Only) on September 02, 2024.
Post such allotment, the issued, subscribed and paid-up share capital of the Company increased to Rs. 8,95,62,130/- (Rupees Eight Crore Ninety Five Lakhs Sixty-Two Thousand One Hundred and Thirty only).
e) Public Issue (Initial Public Offer)
During the year under review, the Company conducted its Initial Public Offer of 61,30,000 Equity Shares of face value of Rs. 5/- each fully paid for cash at a price of Rs. 124/- per Equity Share (including a share premium of Rs. 119/- per Equity Share) aggregating to Rs. 76,01,20,000/- (Rupees Seventy-Six Crore One Lakh Twenty Thousand Only) comprising a fresh issue of
53.34.000 Equity Shares of face value of Rs.5 each fully paid aggregating to Rs. 66,14,16,000/- (Rupees Sixty-Six Crore Fourteen Lakh Sixteen Thousand Only) and an Offer for Sale of 7,96,000 Equity Shares of face value of Rs.5 each fully paid aggregating to Rs. 9,87,04,000/- (Rupees
Nine Crore Eighty-Seven Lakh Four Thousand Only) by the Selling Shareholders. 3,07,000 Equity Shares of face value of Rs.5 each were reserved for subscription by Market Maker and a Net Offer to the public of 58,23,000 Equity Shares of face value of Rs.5 each fully paid up is hereinafter referred to as the Net Offer. The Offer and the Net Offer shall constitute 26.37 % and 25.05 % respectively of the post offer paid up Equity Share Capital of our Company.
9. SUCCESSFUL LISTING ON NATIONAL STOCK EXCHANGE OF INDIA LIMITED:
We are delighted to announce that, your Companys shares were listed on the National Stock Exchange of India Limited (NSE-Emerge) on January 24, 2025 under the trading symbol "EMAPARTNER" marking a significant milestone in our growth journey.
Your directors have placed on record their appreciation for the contributions made by the entire IPO team, with all the dedication, diligence and commitment that led to the successful listing of the Companys equity shares.
Furthermore, the success of the IPO reflects the trust and faith reposed in the Company by its investors, clients and business partners. Your directors thank them for their confidence in the Company.
10. LISTING FEES:
Your Company has paid the requisite Annual Listing Fees for the Year 2024-25 to the National Stock Exchange of India Limited, where its securities are listed.
11. DIVIDEND:
To strengthen the financial position of the Company and to augment working capital, your directors did not declare any dividend, including interim dividend.
12. DEPOSITS:
Your Company has not accepted or renewed any amount falling within the purview of the provisions of Section 73 of the Companies Act 2013, ("The Act") and other applicable rules thereunder during the year under review. Hence, the requirement for furnishing details is not applicable.
13. PARTICULARS OF LOANS, GUARANTEES AND INVESTMENTS UNDER SECTION 186 OF THE ACT:
Pursuant to the provisions of Section 186 of the Act read with the Companies (Meetings of Board and its Powers) Rules, 2014 and Schedule V of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), particulars relating to Loans, Guarantees and Investments are furnished in the notes to the Financial Statements, forming part of this Annual Report and also appended in "Annexure - I" to the Boards report.
14. PARTICULARS OF CONTRACTS OR ARRANGEMENTS MADE WITH RELATED PARTIES:
During the year under review, all the transactions/ contracts/arrangements of the nature as specified in Section 188(1) of the Companies Act, 2013 entered by the Company with related party(ies) are in the ordinary course of business and on an arms length basis.
During the year under review, the Company had not entered into any contract / arrangement / transaction with related parties which could be considered material in accordance with the policy of the Company on materiality of related party transactions, or which is required to be reported in Form No. AOC-2 in terms of Section 134(3)(h) read with Section 188 of the Act and Rule 8(2) of the Companies (Accounts) Rules, 2014.
The Board of Directors have approved a policy on related party transactions which is placed on the Companys website at https://www.emapartners.in/ investor-relation/Policies.
15. DETAILS OF SUBSIDIARIES, JOINT VENTURES OR ASSOCIATES:
Your Company has no associate or joint venture company.
The Company has the following Subsidiaries including Step down Subsidiaries:
Pursuant to the provisions of Section 129(3) of the Act, a statement containing the salient features of financial statements of the Companys subsidiaries in Form No. AOC-1 is appended in "Annexure-N" to the Boards report.
The Board of Directors has approved a policy for determining Material Subsidiaries, which is placed on the Companys website at https://www.emapartners. in/investor-relation/Policies. Your Company has two material subsidiaries i.e. EMA Partners Executive Search Private Limited and EMA Partners Executive Search Limited (Dubai).
Pursuant to the requirements of Section 136 of the Act, the Standalone and Consolidated financial statements, along with relevant documents and audited financial statements of the subsidiaries, are hosted on the Companys website https://www. emapartners.in/investor-relation/Subsidiary.
16. MANAGEMENT DISCUSSION AND ANALYSIS (MD&A) REPORT:
Pursuant to the provisions of Part B of Schedule V read with Regulation 34(3) of the Listing Regulations, the Management Discussion and Analysis capturing your Companys performance, industry trends
and other material changes with respect to your Company and its Subsidiaries, wherever applicable, are provided in a separate section and forms part of this Annual Report.
17. EXTRACT OF ANNUAL RETURN:
In terms of Section 92(3) read with Section 134(3) (a) of the Act and Rule 12 of the Companies (Management and Administration) Rules, 2014, the annual return as on March 31, 2025 is available on the Companys website at https://www.emapartners. in/investor-relation/Financial-Annual-Returns.
18.INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY WITH REFERENCE TO THE FINANCIAL STATEMENTS:
The Company has an adequate Internal Control System commensurate with the size and nature of its business. These controls ensure proper recording and reporting of financial transactions, compliance with applicable laws and regulations and protection of assets. The internal control system includes defined roles and responsibilities, standard operating procedures, periodic internal audits and regular management reviews. The Company has also implemented checks for segregation of duties and approval mechanisms for key transactions.
The Audit Committee periodically reviews the adequacy and effectiveness of these controls. Based on the reviews and audit findings, no material weakness was observed during the year under review.
19. COMPANYS POLICY RELATING TO DIRECTORS APPOINTMENT AND PAYMENT OF REMUNERATION TO KEY MANAGERIAL PERSONNEL(S) AND EMPLOYEES:
In accordance with the provisions of Section 134(3)(e) and Section 178(2) of the Act, the Board of Directors has adopted a comprehensive Nomination and Remuneration Policy. The Policy outlines a structured framework for the appointment, remuneration and evaluation of Directors, Key Managerial Personnel (KMPs) and Senior Management of the Company.
The Policy is based on the principles of fairness, transparency, merit and performance orientation. It sets out the criteria for determining qualifications, positive attributes and independence of Directors and lays down the approach for fixing remuneration of Executive Directors, Non-Executive Directors (through sitting fees), KMPs and Senior Management.
Furthermore, the Policy also guides the Nomination and Remuneration Committee and the Board in identifying suitable candidates for appointment and in conducting performance evaluations in a fair and objective manner.
The Nomination and Remuneration Policy of your Company is available on the Companys website at https://www.emapartners.in/investor-relation/ Policies.
20. BOARD EVALUATION:
Pursuant to the corporate governance requirements as prescribed in the Act and the Listing Regulations, the Board of Directors has carried out an annual evaluation of its own performance, Board Committees and of individual directors.
Pursuant to the applicable provisions of the Act and the Listing Regulations, the Nomination and Remuneration Committee of the Board shall specify the manner for effective evaluation of the performance of the Board, its Committee and Individual Directors (including Independent Directors) which includes criteria for performance evaluation of non-executive directors and executive directors.
The Board has devised a questionnaire to evaluate the performance of the Board, its Committees and Individual Directors.
In a separate meeting of Independent Directors, performance of Non-Independent Directors, performance of the Board as a whole, performance of the Committee(s) of the Board and performance of the Chairman was evaluated, taking into account the views of other Directors.
The Boards performance was evaluated by the Board after seeking inputs from all directors, based on criteria such as board composition and structure, effectiveness of board processes, information sharing and functioning.
The same was discussed in the Board meeting, where the performance of the Board, its Committees and individual directors was evaluated and the performance evaluation of Independent Directors was conducted by the entire Board, excluding the Independent Director being evaluated.
21. DECLARATION FROM INDEPENDENT DIRECTORS:
The Company has received a declaration from all the Independent Directors of the Company confirming that they meet the criteria of independence as prescribed both under Section 149(6) of the Act and Regulation 16(1)(b) of the Listing Regulations.
Further, the Independent Directors have also submitted their declaration in compliance with the provisions of Rule 6(3) of the Companies (Appointment and Qualifications of Directors) Rules, 2014, which mandated the inclusion of Independent Directors names in the data bank of Indian Institute of Corporate Affairs ("IICA").
As on the year under review, the following directors on your Board were Independent:
1. Dr. Archana Niranjan Hingorani
2. Rajat Kumar Jain
In the opinion of the Board, the Independent Directors fulfil the criteria of independence specified in Section 149(6) of the Act read with Rules 5 and 6 of the Companies (Appointment and Qualifications of Directors) Rules, 2014 and Regulation 16(1)(b) of the Listing Regulations.
22. MEETING OF INDEPENDENT DIRECTORS:
In terms of requirements of Schedule IV of the Act, the Independent Directors of the Company met separately on March 28, 2025, inter alia to review
the performance of Non-Independent Directors (including the Chairman), the entire Board and the quality, quantity and timeliness of the flow of information between the Management and the Board.
23.BOARD OF DIRECTORS, THEIR MEETINGS AND KEY MANAGERIAL PERSONNEL:
a. Board of Directors-
Your Company has an appropriate mix of Executive, Non-executive and Independent Directors to maintain its independence and separate its functions of governance and management.
The Board comprised two Executive Directors, three Independent Directors and one NonExecutive and Non-Independent Director, including one Women Director. None of the Directors are disqualified under Section 164 of the Act. Furthermore, in the opinion of the Board, all the Independent Directors possess the requisite expertise, integrity, and experience.
The Board of Directors of your Company are:
Sr. No. Name of the Member | Designation |
1. Krishnan Sudarshan@ | Chairman & Managing Director |
2. Subramanian Krishnaprakash* | Whole-time Director |
3. Shekhar Ganapathy | Non-Executive NonIndependent Director |
4. Dr. Archana Niranjan Hingorani* | Non-Executive Independent Director |
5. Arun Dasmahapatra* | Non-Executive Independent Director |
6. Rajat Kumar Jain* | Non-Executive Independent Director |
7. Anand Balasundaram# | Additional NonExecutive Independent Director |
@Krishnan Sudarshan, Managing Director of the Company was also designated as Chairman of the Board w. e. f July 09, 2024.
A
Subramanian Krishnaprakash was re-designated from Director to Whole-time Director of the Company w.e.f. July 09, 2024.*Dr. Archana Niranjan Hingorani and Rajat Kumar Jain were appointed as Non-Executive independent Directors w.e.f. July 10, 2024.
$
Arun Dasmahapatra was appointed as Non-Executive Independent Director w.e.f. July 10, 2024 and he resigned on March 05, 2025.#Anand Balasundaram was appointed as an Additional Non-Executive Independent Director w.e.f. April 11, 2025.
The Board meets at regular intervals to discuss and decide on Companys business policies and strategy apart from other business of the Board.
The notice of Board meetings is given in accordance with the provisions of the Companies Act, 2013, and applicable rules thereunder. The agenda for the Board/ Committee meetings includes detailed notes on the items to be discussed, enabling directors/ members to make informed decisions.
During the year under review, the Board of Directors duly met 11 (Eleven) times viz. on April 23, 2024, June 11, 2024, July 9, 2024, July 10, 2024, August 21, 2024, September 4, 2024, September 5, 2024, December 23, 2024, January 6, 2025, January 9, 2025 and February 11, 2025. The intervening gap between two consecutive Board meetings did not exceed the stipulated days.
The details of attendance of the directors at the meetings of the Board of Directors held during the year under review are as under:
Name of the Directors | Designation | No. of Meetings | |
Held | Attended | ||
Krishnan Sudarshan | Chairman & Managing Director | 11 | 11 |
Subramanian Krishnaprakash | Whole-time Director | 11 | 11 |
Shekhar Ganapathy | Non-Executive Non Independent Director | 11 | 7 |
Dr. Archana Niranjan Hingorani | Non-Executive Independent Director | 7 | 7 |
Arun Dasmahapatra$ | Non-Executive Independent Director | 7 | 7 |
Rajat Kumar Jain | Non-Executive Independent Director | 7 | 7 |
$
Arun Dasmahapatra was appointed as Non-Executive Independent Director w.e.f. July 10, 2024 and he resigned on March 05, 2025.b. Key Managerial Personnel-
Pursuant to the provisions of Section 203 of the Act, the Key Managerial Personnel(s) [KMP(s)] of the Company are:
Sr. No. Name of the Members | Designation |
1. Krishnan Sudarshan | Chairman & Managing Director |
2. Subramanian Krishnaprakash | Whole-time Director |
3. Manishkumar Dhanuka* | Chief Financial Officer |
4. Smita Singh@ | Company Secretary & Compliance Officer |
*Manishkumar Dhanuka was appointed as Chief Financial Officer w.e.f. August 21, 2024 and he resigned on June 30, 2025 due to health reasons.
@Smita Singh was appointed as Company Secretary & Compliance Officer w.e.f. July 09, 2024.
c. Details of Directors and/or KMP(s) who were appointed or have resigned during the year-
Given the requirements under the IPO process and in compliance with the applicable provisions of the Companies Act, 2013 and the Listing Regulations, the following persons were appointed / resigned during the year under review:
Viswanathan Subramaniam (DIN: 02651023) and Sangeetha Sudarshan (DIN: 02299863) resigned as Directors of the Company with effect from May 23, 2024. The Board of Directors placed on record their sincere appreciation for the contributions made by them during their tenure as Directors of the Company.
Smita Singh was appointed as the Company Secretary and Compliance Officer with effect from July 09, 2024.
Dr. Archana Hingorani (DIN: 00028037), Arun Dasmahapatra (DIN: 01550644), and Rajat Kumar Jain (DIN: 00046053) were appointed as Independent Directors of the Company with effect from July 10, 2024, to hold office for a term of five (5) consecutive years from the date of their appointment. In the opinion of the Board, the aforesaid directors possess the integrity, expertise and experience (including proficiency) required for appointment as Independent Directors of the Company.
Ravi Swamy was appointed as Chief Financial Officer with effect from July 09, 2024 and he resigned on August 21, 2024.
Manishkumar Dhanuka was appointed as Group Chief Financial Officer with effect from August 21, 2024.
Ravi Swamy resigned as Director with effect from August 28, 2024. The Board of Directors placed on record their sincere appreciation for the contributions made by him during his tenure as Director of the Company.
Arun Dasmahapatra (DIN: 01550644) resigned as an Independent Director with effect from March 05, 2025. The Board of Directors placed on record their sincere appreciation for the contribution made by Arun Dasmahapatra during his tenure as Independent Director of the Company.
The Board of Directors of the Company, on the recommendation of the Nomination and Remuneration Committee, appointed Anand Balasundaram (DIN: 02792009) as an Additional Non-Executive Independent Director of the Company for a period of five (5) consecutive years with effect from April 11, 2025, subject to approval of members at the ensuing 22nd Annual General Meeting. The necessary resolution in this regard has been incorporated in the notice of the ensuing Annual General Meeting of the Company along with his brief profile.
d. Retirement by Rotation-
As per the provisions of Section 152(6) of the Act, Krishnan Sudarshan (DIN: 01029826), Managing Director of the Company retires by rotation at the ensuing 22nd Annual General Meeting ("AGM") and being eligible, offers himself for re-appointment.
Your Board recommends his reappointment and the agenda seeking approval from Members is included in the Notice convening the 22nd Annual General Meeting. The necessary resolution recommending his reappointment forms part of the AGM Notice.
24.LOANS FROM DIRECTORS:
During the year under review, the Company has not availed any loans from its directors.
25. REMUNERATION / COMMISSION DRAWN FROM SUBSIDIARY COMPANIES:
During the year under review, the directors of the Company have not received remuneration / commission from the subsidiary Companies.
26. CORPORATE SOCIAL RESPONSIBILITY (CSR):
The provisions of Section 135 of the Act read with the Companies (Corporate Social Responsibility Policy) Rules, 2014 do not apply to your Company for the year under review.
27. COMMITTEES OF BOARD OF DIRECTORS OF THE COMPANY:
The Company has duly constituted the following mandatory Committees in terms of the provisions of the Act & the Listing Regulations viz.,
a. Audit Committee;
b. Nomination and Remuneration Committee; and
c. Stakeholders Relationship Committee.
a. AUDIT COMMITTEE
Your Company has duly constituted an Audit Committee w.e.f. August 07, 2024 in compliance with the provisions of Section 177 of the Act read with Rule 6 of the Companies (Meeting of Board and its Powers) Rules, 2014 and Regulation 18 of the Listing Regulations. The members of the Audit Committee possess sound knowledge on accounts, audit, finance, taxation, internal controls, etc.
The Audit Committee of your Company comprises of the following members as on the end of the year:
Sr. No Name of the Members | Designation | Nature of Directorship |
1. Dr. Archana Niranjan Hingorani | Chairperson | Non-Executive Independent Director |
2. Rajat Kumar Jain | Member | Non-Executive Independent Director |
3. Krishnan Sudarshan | Member | Chairman and Managing Director |
The Audit Committee was reconstituted w.e.f. June 02, 2025:
Sr. No Name of the Members | Designation | Nature of Directorship |
1. Dr. Archana Niranjan Hingorani | Chairperson | Non-Executive Independent Director |
2. Rajat Kumar Jain* | Member | Non-Executive Independent Director |
3. Anand Balasundaram# | Member | Non-Executive Independent Director |
4. Krishnan Sudarshan | Member | Chairman and Managing Director |
*Rajat Kumar Jain has stepped down as a member of the Audit committee w.e.f. June 02, 2025.
#Anand Balasundaram has been added as a member of the Audit Committee w.e.f. June 02, 2025.
During the year under review, the Audit Committee duly met 5 (Five) times viz. on August 21, 2024, September 5, 2024, December 23, 2024, January 6, 2025 and February 11, 2025.
The number of meetings attended by each member during the year under review are as follows:
Name of the members | Designation | No. of Meetings | |
Held | Attended | ||
Dr. Archana | Chairperson | 5 | 5 |
Niranjan Hingorani | |||
Rajat Kumar Jain | Member | 5 | 5 |
Krishnan | Member | 5 | 5 |
Sudarshan |
During the year under review, all recommendations made by the Audit Committee to the Board of Director were accepted by the Board.
b. NOMINATION AND REMUNERATION COMMITTEE
Your Company has constituted a Nomination and Remuneration Committee w.e.f. August 07, 2024 in compliance with the provisions of Section 178 of the Act, 2013, read with Rule 6 of the Companies (Meetings of Board and its Powers) Rules, 2014 and Regulation 19 of the Listing Regulations.
The Nomination and Remuneration Committee of your Company comprises the following members as on the end of the year:
Sr. No Name of the Members | Designation | Nature of Directorship |
1. Arun Dasmahapatra | Chairperson | Non-Executive Independent Director |
2. Rajat Kumar Jain | Member | Non-Executive Independent Director |
3. Shekhar Ganapathy | Member | Non-Executive Non Independent Director |
4. Krishnan Sudarshan | Member | Chairman and Managing Director |
The Nomination and Remuneration Committee was reconstituted w.e.f. April 08, 2025 and June 02, 2025:
Sr. No Name of the Members | Designation | Nature of Directorship |
1. Arun Dasmahapatra* | Chairperson | Non-Executive Independent Director |
2. Dr. Archana Niranjan Hingorani$ | Chairperson | Non-Executive Independent Director |
3. Anand Balasundaram# | Chairperson | Non-Executive Independent Director |
4. Rajat Kumar Jain | Member | Non-Executive Independent Director |
5. Shekhar Ganapathy | Member | Non-Executive Non Independent Director |
6. Krishnan Sudarshan | Member | Chairman and Managing Director |
*Arun Dasmahapatra resigned from the Board of the Company as an Independent Director w.e.f. March 05, 2025.
$Dr Archana Niranjan Hingorani was appointed w.e.f. April 08, 2025 as Chairperson of the Committee due to resignation of Chairperson of the Committee and stepped down as Chairperson w.e.f. June 02, 2025.
#Anand Balasundaram has been appointed as Chairperson and Member of the Committee w.e.f. June 02, 2025.
During the year under review, the Nomination and Remuneration Committee duly met 2 (Two) times viz. on August 21, 2024 and September 4, 2024.
The number of meetings attended by each member during the year under review are as follows:
Name of the members | Designation | No. of Meetings | |
Held | Attended | ||
Arun Dasmahapatra | Chairperson | 2 | 2 |
Rajat Kumar Jain | Member | 2 | 2 |
Shekhar Ganapathy | Member | 2 | 2 |
Krishnan Sudarshan | Member | 2 | 2 |
The Nomination and Remuneration Policy of your Company has been made available on the website of the Company i.e., https://www. emapartners.in/investor-relation/Policies.
c. STAKEHOLDERS RELATIONSHIP
COMMITTEE
Your Company has constituted a Stakeholders Relationship Committee w.e.f. August 07, 2024 in compliance with the provisions of Section 178(5) of the Act and Regulation 20 of the Listing Regulations.
The Stakeholders Relationship Committee of your Company comprises of the following members as on the end of the year:
Sr. No Name of the Members | Designation | Nature of Directorship |
1. Shekhar Ganapathy | Chairperson | Non-Executive Non-Independent Director |
2. Rajat Kumar Jain | Member | Non-Executive Independent Director |
3. Subramanian Krishnaprakash | Member | Whole-time Director |
4. Krishnan Sudarshan | Member | Chairman and Managing Director |
No committee meetings held during the year under review.
28.INTERNAL COMPLAINT COMMITTEE:
In compliance with the provisions of the Section 4 of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 your Company has constituted an Internal Complaints Committee ("ICC Committee"). The same was reconstituted during the year under review and the members of the Committee were:
Sr. No Name of the Members | Designation in Committee | Designation in Company |
1. Smita Singh | Presiding Officer | Company Secretary & Compliance Officer |
2. Krishnan Sudarshan | Member | Chairman and Managing Director |
3. Pamela Lobo | Member | Sr. Executive Assistant & Office manager |
4. Sonali Pol | External Member | NA |
29.DISCLOSURES UNDER SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION,
PROHIBITION & REDRESSAL) ACT, 2013:
Your Company is committed to provide a safe and conducive work environment to its employees. All employees (permanent, contractual, temporary and trainees) are covered under this policy. The Company has complied with the provisions relating to the constitution of Internal Complaints Committee under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013. The Company is strongly opposed to sexual harassment and employees are made aware about the consequences of such acts, the constitution of ICC committee and their right to raise a complaint in this regard at the designated Email ID posh@ema- partners.com. The following is a summary of sexual harassment complaints received and disposed off during the year under review.
Sr. No. Particulars | Number |
1. No. of complaints pending at the beginning of the Financial Year | 0 |
2. No. of complaints received during the Financial Year | 0 |
3. No. of complaints disposed off during the Financial Year | 0 |
4. The number of cases pending for a period exceeding 90 days | 0 |
5. No. of complaints pending at the end of the Financial Year | 0 |
The Company has a zero-tolerance policy towards sexual harassment in the workplace. It has adopted a Policy on the Prevention, Prohibition and Redressal of sexual harassment at the workplace, in line with the provisions of the Sexual Harassment of Women at the Workplace (Prevention, Prohibition and Redressal) Act, 2013, and the Rules made thereunder. The Policy under the Sexual Harassment
of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013, of your Company has been made available on the Companys website, i.e., https://www.emapartners.in/investor-relation/ Policies.
30. VIGIL MECHANISM / WHISTLE BLOWER AND RISK MANAGEMENT POLICY:
Pursuant to the provisions of Section 177 (9) of the Act read with Rule 7 of the Companies (Meetings of Board and its Powers) Rules, 2014 and Regulation 22 of the Listing Regulations your Company already has in place "Vigil Mechanism Policy" (Whistle Blower Policy) on the website of the your Company https://www.emapartners. in/investor-relation/Policies. The purpose of the Policy is to enable employees to raise concerns regarding unacceptable improper practices and/or any unethical practices in the organization without knowledge of the Management. All employees shall be protected from any adverse action for reporting any unacceptable or improper practice and/or any unethical practice, fraud or violation of any law, rule or regulation. Employees have the right/option to report their concerns/grievances to the Chairperson of the Audit Committee. The Company is dedicated to maintaining the highest standards of ethical, moral, and legal conduct as a foundation for strong corporate governance.
31. MATERNITY BENEFIT COMPLIANCE:
Your Company is in compliance with the provisions of the Maternity Benefit Act, 1961 and extends all applicable benefits to eligible women employees as per the statutory requirements.
32. AUDITORS & AUDITORS REPORTS:
a) Statutory Auditors of the Company and their observations, if any on accounts for the year ended March 31, 2025:
As per the provisions of Section 139 of the Act, M/s. A P Sanzgiri & Co., Chartered Accountants (FRN: 116293W), Mumbai were appointed as Statutory Auditors of the Company in the 18th Annual General Meeting held on November 30, 2021 for a period of five consecutive years up to the conclusion of the 23rd Annual General Meeting to be held in the year 2026, at a remuneration mutually agreed upon by the Board of Directors and Statutory Auditors.
The Auditors Report on the Financial Statements of the Company for the year ended March 31, 2025 is unmodified i.e., it does not contain any
qualification, reservation or adverse remark. The Statutory Auditors Report is enclosed with the Financial Statements forming part of the Annual Report.
There were no incidences of reporting of frauds by Statutory Auditors under Section 143(12) of the Act read with the Companies (Accounts) Rules, 2014.
b) Internal Auditors of the Company:
As per the provisions of Section 138 of the Act and on the recommendation of the Audit Committee, M/s. V C Shah & Co., Chartered Accountants, (FRN 109818W) Mumbai were appointed as Internal Auditors of the Company in the Board Meeting held on February 11,2025 for the Financial Year 2024-25, at a remuneration decided by the Company excluding applicable taxes and reimbursement of out-of-pocket expense at actuals, if any.
The Internal Auditors submit their findings and report to the Audit Committee of the Company.
c) Cost records and Cost Auditors of the Company:
In terms of the provisions of Section 148 of the Act read with the rules made thereunder, the maintenance of cost records and provisions of cost audit are not applicable to your Company.
d) Secretarial Auditors of the Company:
The Board on the recommendation of the Audit Committee appointed M/s. Sonali Pol & Co. (formerly known as S Pawaskar & Co.), Company Secretaries, Mumbai, as Secretarial Auditors of the Company to conduct Secretarial Audit of your Company for the Financial Year 2024-25 and their report is appended in "Annexure-IN" to the Boards report.
The Secretarial Auditors report does not contain any qualifications, reservations, or adverse remarks or disclaimer.
33.NON-APPLICABILITY OF THE INDIAN ACCOUNTING STANDARDS:
As per provision of regulation Rule 4(1) of the Companies (Indian Accounting Standards) Rules, 2015 notified vide Notification No. G.S.R 111 (E) on 16th February, 2015, Companies whose shares are listed on NSE EMERGE as referred to in Chapter XB of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, are exempted from the compulsory requirements of adoption of IND-AS w.e.f. 1st April, 2017.
34. CODE FOR PREVENTION OF INSIDER TRADING:
Based on the requirements under the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the Code of Conduct for Insider Trading (Code), as approved by the Board is in force by the Company. The Company follows the concept of Trading Window Closure to prevent its Directors, Officers, designated employees, their relatives and other connected employees from trading in the Companys securities when they have access to Unpublished Price Sensitive Information (UPSI).This Code of Conduct also includes code of practices and procedures for fair disclosure of unpublished price sensitive information and has been made available on the Companys website and a comprehensive Policy for enquiry of leak of Unpublished Price Sensitive Information on https:// www.emapartners.in/investor-relation/Policies.
35. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUT GO:
The information on conservation of energy, technology absorption and foreign exchange earnings and outgo stipulated under Section 134(3) (m) of the Act, read with Rule 8 of the Companies (Accounts) Rules, 2014, is appended in "Annexure- IV" to the Boards report.
36. DETAILS OF APPLICATION MADE OR PROCEEDING PENDING UNDER THE INSOLVENCY AND BANKRUPTCY CODE, 2016:
There were no applications made or any proceedings were pending against your Company under the Insolvency and Bankruptcy Code, 2016 during the year under review. Furthermore, there was no instance of valuing the amount for the settlement of loan(s) from Banks and Financial Institutions during the financial year under review.
37. CORPORATE GOVERNANCE:
The Company understands and respects its fiduciary role and responsibility towards its stakeholders and society at large and strives to serve their interests, resulting in creation of value for all its stakeholders. The Company has been listed on SME Emerge Platform of NSE and by virtue of Regulation 15 of the Listing Regulations, the compliance with the corporate governance provisions as specified in Regulation 17 to 27 and clauses (b) to (i) and (t) of
sub-regulation (2) of Regulation 46 and Para C, D and E of Schedule V are not applicable to the Company. However, the Company continues to adhere to the best practices prevailing in Corporate Governance and follows the same in its true spirit. Hence, the Corporate Governance Report does not form part of this Annual Report.
38. DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS IMPACTING THE GOING CONCERN STATUS AND COMPANYS OPERATIONS IN FUTURE:
Pursuant to the requirement of Section 134(3)(q) of the Act read with Rule 8(5)(vii) of the Companies (Accounts) Rules, 2014, it is confirmed that during the year under review, there were no significant or material orders passed by the Regulators or Courts or Tribunals impacting the going concern status and your Companys operations in future.
39. ACQUISITION OF COMPANIES / INVESTMENT IN ASSOCIATES / SUBSIDIARIES DURING THE YEAR UNDER REVIEW:
During the year under review, the Company made the following acquisitions: NIL
During the year under review, the Company made the following Investments: NIL
40. TRANSFER OF UNCLAIMED DIVIDEND TO INVESTOR EDUCATION AND PROTECTION FUND:
There were no unpaid / unclaimed dividends declared and paid in previous years and hence the provisions of Section 125 of the Act do not apply for the year under review.
41. SECRETARIAL STANDARDS OF ICSI:
Your Company is in compliance with the Secretarial Standards on Meetings of the Board of Directors ("SS-1") and General Meetings ("SS-2") issued by The Institute of Company Secretaries of India ("ICSI").
42. PARTICULARS OF EMPLOYEES, REMUNERATION AND RELATED DISCLOSURES:
The information required under Section 197(12) of the Act read with Rule 5 (2) and 5(3) of the Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014 and other applicable Rules is appended in "Annexure-V" to the Boards report. A statement showing the names of the top ten employees in terms of remuneration drawn and names and other particulars of the employees drawing remuneration in excess of the limits set out in the said rules forms part of this Report.
Disclosures relating to remuneration and other details as required under Section 197(12) of the Act read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 forms part of this Report.
I n accordance with the provisions of the second proviso to Section 136(1) of the Companies Act, 2013 and as advised, the Annual Report, excluding the aforesaid information, is being circulated to the members of the Company. Members who wish to access the excluded information may request the same by writing to investor@emapartners.in.
43. MANAGING DIRECTOR (MD) AND CHIEF FINANCIAL OFFICER (CFO) CERTIFICATE:
In terms of the Listing Regulations, the certificate, as prescribed in Part B of Schedule II of the said Regulations, has been obtained from the Chief Financial Officer and Managing Director of the Company for the financial year 2024-25 with regard to the financial statements and other matters. The said certificate forms part of this Annual Report.
44. DEPOSITORY:
The Companys shares are compulsorily tradable in electronic form. As on date, 100% of the Companys Paid-up Equity Share Capital are in dematerialized form with both the Depositories viz. National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). The Company has appointed Bigshare Services Private Limited, SEBI registered Registrar and Share Transfer Agent.
45. EMPLOYEE STOCK OPTION SCHEMES ("ESOS"):
To attract, retain and motivate high-performing talent, the Company extends share-based benefits to eligible employees. These initiatives are designed to foster a strong alignment between individual performance and the Companys strategic objectives, while also encouraging long-term commitment and a sense of ownership among employees.
In line with this objective, the Company has implemented Employee Stock Option Schemes, namely:
a. EMA Employee Stock Option Scheme 2024:
The Company had implemented an employee stock option plan namely EMA Employee Stock Option Scheme 2024" ("EMA ESOS 2024") for the employees of the Company and its subsidiary(ies). EMA ESOS 2024 was approved at the 2nd Extra Ordinary General Meeting of the Company for the FY 2024-25 held on August 23, 2024 i.e. prior to Companys initial public offer ("IPO"), with an objective to align employees interests with those of the shareholders and promoting employee retention and longterm performance.
Subsequently, the Company successfully completed its IPO, listing its shares on January 24, 2025 on National Stock Exchange Limited (SME EMERGE Platform) and in terms of Regulation 12(1) of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 ("SEBI SBEB Regulations"), any fresh grant of Options post listing can be made under EMA ESOS 2024 only in compliance with the SEBI SBEB Regulations and post ratification of same by the members of the Company.
Accordingly, ratification of EMA ESOS 2024 was recommended by the Nomination and Remuneration Committee and approved by the Board of Directors of the Company at their respective meetings held on May 05, 2025 and it was further ratified by the members of the Company vide resolution dated July 05, 2025 passed through Postal Ballot. The EMA ESOS 2024 is available on the Companys website at https://www.emapartners.in/investor-relation/ Disclosures-under-Reg-46-of-the-LODR.
b. EMA Partners India Limited Employee Stock Option Scheme 2025:
To motivate the key work force, seeking their contribution to the corporate growth and to bring skin in the game, the Company proposes to implement a new employee stock option scheme namely EMA Partners India Limited Employee Stock Option Scheme 2025 ("ESOS 2025" / "Scheme") contemplating grant of employee stock options to employees of the Company and its subsidiary company(s).
ESOS 2025 was recommended by the Nomination and Remuneration Committee and approved by the Board of Directors of the Company at their respective meetings held on May 21, 2025. It was further approved by the members of the Company vide resolution dated July 05, 2025 passed through Postal Ballot.
It is hereby affirmed that EMA ESOS 2024 and ESOS 2025 instituted by the Company are in compliance with the SEBI SBEB Regulations, as amended from time to time and the resolutions passed by the members approving the same. The EMA ESOS 2025 is available on the Companys website at https://www. emapartners.in/investor-relation/Disclosures- under-Reg-46-of-the-LODR.
46. BOARD POLICIES:
In compliance with the Listing Regulations, the Company has formulated and adopted various policies as mandated for all listed entities.
These policies are aimed at ensuring accountability, fairness and adherence to regulatory norms and are available on the Companys website https://www. emapartners.in/investor-relation/Policies.
47. DECLARATION FOR CODE OF CONDUCT:
Commitment to ethical professional conduct is a must for every employee, including Board members and senior management personnel of the Company. The duties of Directors, including duties as an Independent Director as laid down in the Act, also form part of the Code of Conduct. The Code of Conduct is available on the website of the Company https://www.emapartners.in/investor-relation/ Policies. All Board members and senior management personnel affirm compliance with the Code of Conduct annually.
48. GENERAL DISCLOSURES:
Your directors state that no disclosure or reporting is required in respect of the following items as there were no transactions on these items during the year under review:
I. The Company has not issued any shares with differential rights and hence no information as per provisions of Section 43(a)(ii) of the Act read with Rule 4(4) of the Companies (Share Capital and Debenture) Rules, 2014 is furnished.
II. The Company has not issued any sweat equity shares during the year under review and hence no information as per provisions of Section 54(1)(d) of the Act read with Rule 8(13) of the Companies (Share Capital and Debenture) Rules, 2014 is furnished.
III. The Company has not issued any equity shares under Employees Stock Option Scheme during the year under review and hence no information as per provisions of Section 62(1)(b) of the Act read with Rule 12(9) of the Companies (Share Capital and Debenture) Rules, 2014 is furnished.
IV. During the year under review, there were no instances of non-exercising of voting rights in respect of shares purchased directly by employees under a scheme pursuant to Section 67(3) of the Act read with Rule 16(4) of Companies (Share Capital and Debentures) Rules, 2014.
49. THE DETAILS OF DIFFERENCE BETWEEN THE AMOUNT OF THE VALUATION DONE AT THE TIME OF ONE TIME SETTLEMENT AND THE VALUATION DONE WHILE TAKING LOAN FROM THE BANKS OR FINANCIAL INSTITUTIONS ALONG WITH THE REASONS THEREOF:
During the financial year under review, there was no instance of one-time settlement of loans / financial assistance taken from Banks or Financial Institutions, hence the Company was not required to carry out valuation of its assets for the said purpose.
50. DIRECTORS RESPONSIBILITY
STATEMENT:
Pursuant to the requirement of Section 134(5) of the Act, the Board of Directors of your Company, to the best of their knowledge and ability, confirm that:
(a) In the preparation of the Annual Accounts, the applicable accounting standards have been followed and there are no material departures.
(b) The Directors have selected such accounting policies and applied them consistently and made judgements and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of your Company at the end of the Financial Year and of the profit of your Company for that period.
(c) The Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of your Company and for preventing and detecting fraud and other irregularities.
(d) The Directors have prepared the Annual Accounts on a going concern basis.
(e) The Directors have laid down internal financial controls to be followed by your Company and that such internal financial controls are adequate and are operating effectively.
(f) The Directors have devised proper systems to ensure compliance with the provisions of all
applicable laws and that such systems were adequate and operating effectively.
51. GREEN INITIATIVES:
In compliance with Regulation 36 of the Listing Regulations, notice of the 22nd AGM along with the Annual Report 2024-25 is being sent only through electronic mode to those Members whose email addresses are registered with the Company / Depositories. Members may note that the Notice and Annual Report 2024-25 will also be available on the Companys website https://www.emapartners. in/investor-relation/General-Meetings-Annual- General-Meeting.
52. CAUTIONARY STATEMENT
The Annual Report including those which relate to the Directors Report, management discussion and analysis report may contain certain statements on the Companys intent expectations or forecasts that appear to be forward-looking within the meaning of applicable securities laws and regulations while actual outcomes may differ materially from what is expressed herein.
53. ACKNOWLEGDEMENT:
The Board of Directors extends its deepest gratitude to all employees across our organization, whose hard work, dedication and unwavering commitment have been the pillars of our success. For this, we are profoundly thankful.
We would also like to express our sincere appreciation for the enduring cooperation and support we have received from our shareholders, investors, bankers, financial institutions, clients and business partners. Their trust and encouragement have been invaluable in our journey.
Our heartfelt thanks also extend to all regulatory authorities and other stakeholders who have consistently provided guidance and support, contributing to our ongoing growth and success. We look forward to strengthening these relationships as we continue to navigate the path to progress together.
For and On Behalf of the Board of Directors | |
EMA Partners India Limited | |
(Formerly known as EMA Partners India Private Limited) | |
Sd/- | |
Krishnan Sudarshan | |
Chairman & Managing Director | |
DIN: 01029826 | |
Place: Mumbai | |
Date: August 13, 2025 |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.